Marion Leboyer is an expert in Psychiatry at Assistance Publique - Hôpitaux de Paris (France). As of October 2026, ScienceLeadR ranks Marion Leboyer in the top 1% of experts worldwide for Bipolar and Related Disorders, Bipolar Disorder and Mood Disorders. Marion Leboyer has authored 1,093 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 9 of them ongoing. SLR score: 3,104 (community average: 125). How the SLR is computed.

LeadR Profile

3 104 ScienceLeadR Reputation 3104
Network Map

Psychiatry

Subspecialties: Neurology - Genetics - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2026

Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1093

Citations

Citations: 74 177 1st author: 44 Last author: 159 Unique author: 13


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Plasma proteomic signatures in bipolar disorder and their implications for data-driven patient stratification.
PMID 42863721 — cells, bipolar disorder, plasma
Brain Behav Immun20260
Using multi-trait polygenic scores to predict lithium responsiveness in patients with bipolar disorder.
PMID 42841250 — bipolar disorder, phenotype, multiple chronic conditions, machine learning, therapeutics, psychiatry
Br J Psychiatry20260
Toward actionable biomarkers in psychiatry: a collaborative roadmap for precision clinical trials. An ACNP position paper.
PMID 42760290 — pharmaceutical preparations, biomarkers, therapeutics, psychiatry
NPP Digit Psychiatry Neurosci20260
Psychometric validation of research domain criteria, general health, and clinical-psychosocial parts of the minimum dataset of the German Center for Mental Health-informing a Delphi process.
PMID 42631718 — research, psychometrics, nervous system diseases, neurology, mental health, psychiatry
Eur Arch Psychiatry Clin Neurosci20261
Prescription Trends for Bipolar Disorder With and Without Comorbid Substance Use and Anxiety Disorders: A Global Bipolar Cohort Collaborative Study.
PMID 42578538 — comorbidity, bipolar disorder, stress disorders, post-traumatic, prescriptions, psychopharmacology, stress disorders, traumatic, anxiety disorders, therapeutics, attention deficit disorder with hyperactivity
Bipolar Disord20260

Clinical Studies 19

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 3

By phase:

N/A 14
Phase 2 2
Phase 2/Phase 3 1
Phase 3 1
Phase 4 1

By status:

Recruiting 10
Completed 5
Unknown 3
Not yet recruiting 1

By type:

Interventional 15
Observational 4

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 4
multicentric5to9 4
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 36

Ongoing Clinical Trials

9 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Assessment of microglial activation in patients with schizophrenia stratified for C4 complement by PET using 18F DPA 714
2023-504181-38-00 — complement c4, pathology, schizophrenia, complement system proteins
Phase 2/Phase 3Recruiting2025
GynMDD Add On to Supportive Psychotherapy in Mild to Moderate Depression
NCT07416747 — depression, brain, psychotherapy, dietary supplements, signs and symptoms, probiotics, curcumin, gastrointestinal microbiome, glutamine, mental health, microbiota, psychological well-being
N/ARecruiting2026
Medical Comorbidities in Bipolar Disorder
NCT06872398 — comorbidity, bipolar disorder, blood, incidence, blood specimen collection, mental disorders, biomarkers, prevalence, risk factors, therapeutics
N/ARecruiting2024
Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity
NCT05946486 — autoantibodies, immunomodulation, mental disorders, central nervous system, rituximab, therapeutics, nervous system, problem behavior, psychotic disorders, child
Phase 3Not yet recruiting2023
Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia Bipolar Disorder Autism Spectrum Disorder or Resistant Depression
NCT05480826 — depression, cells, genes, bipolar disorder, autism spectrum disorder, microscopy, electron, scanning transmission, mental disorders, autistic disorder, child development disorders, pervasive, schizophrenia, problem behavior, dna
N/ARecruiting2023

LeadR Networks

Main global connection map